Indefinite Delivery Contract HHSF223201710079C

The 8(a) STARS III Government-Wide Acquisition Contract (GWAC) is a $50 billion multiple-award indefinite delivery/indefinite quantity vehicle administered by the General Services Administration's Federal Acquisition Service and awarded to Agisol LLC, a small, minority-owned, woman-owned business based in Marriottsville, Maryland. The competitive 8(a) set-aside GWAC, awarded on February 23, 2022, with an ultimate completion date of July 1, 2026, enables Agisol LLC to provide information...

The Food and Drug Administration (FDA) has awarded a $45 million single-award Indefinite Delivery Contract (IDC) to Source Healthcare Analytics LLC for the "ACCESS TO OUTPATIENT LONGITUDINAL DATA IDIQ" over a 5-year period ending in May 2025. The purpose of this contract is to procure real-world data to aid the FDA in monitoring drug safety and effectiveness. Under this IDC, the FDA has issued Task Order 1, valued at $13,119,440, to Source Healthcare Analytics LLC for the...

The Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) awarded a $75 million indefinite delivery contract to Acumen LLC (doing business as Medric) on September 27, 2024, to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics. This multiple-award, unrestricted competition contract extends through September 29, 2029, and requires the contractor to provide large-scale, longitudinal healthcare...

The key products and services being delivered under this federal contract IDV award are data sources and analytics to support the Food and Drug Administration's (FDA) Biologics Effectiveness and Safety (BEST) Initiative. The prime contractor, CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, was awarded a $50 million multiple award IDV to provide healthcare data and conduct safety analyses for the BEST program. Under a $1.38 million task order, CVS...

The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Source Healthcare Analytics LLC with a potential value of $45 million. Under the contract, Source Healthcare will provide the FDA access to outpatient prescription and patient level drug utilization data over a five-year period ending in May 2025. Task Order 1 was issued with a firm fixed price value of $20.2 million. Source Healthcare will support the FDA's efforts...

This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...

The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through...

This is a $75 million multiple-award Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) to Iqvia Government Solutions Inc. for the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). Under this IDC, Iqvia will provide the FDA with access to large-scale, longitudinal healthcare data from the United States covering tens of millions of...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract for the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The prime contractor, The Lewin Group, Inc. (doing business as Lewing Group Inc.), a subsidiary of UnitedHealth Group Incorporated, will provide data sources containing administrative claims data or claims and electronic...

The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products. Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of...